Insomnia Therapeutics Market Analysis By Treatment Type [Devices, Drugs (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists)], By Sales Channel, And Segment Forecasts, 2018 - 2025

Report ID: GVR-2-68038-213-6
Number of Pages: 101
Format: Electronic (PDF)

Historical Range: 2014 - 2016
Industry: Healthcare

Market Segmentation

Insomnia therapeutics market Product Outlook (Revenue, USD Million, 2014 - 2025)
- Drugs
  - Benzodiazepines
  - Nonbenzodiazepines
  - Antidepressants
  - Orexin antagonists
  - Melatonin antagonists
  - Others
- Devices
Insomnia Therapeutics Market Sales channel Outlook (Revenue, USD Million, 2014 - 2025)
- Prescription
- Over-the-Counter (OTC)
Insomnia Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
  - North America Insomnia Therapeutics Market, By Treatment type
    - Drugs
      - Benzodiazepines
      - Nonbenzodiazepines
      - Antidepressants
      - Orexin antagonists
      - Melatonin antagonists
      - Others
    - Devices
  - North America Insomnia Therapeutics Market, By Sales channel
    - Prescription
    - Over-the-Counter (OTC)
  - The U.S.
    - U.S. Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - U.S. Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
  - Canada
    - Canada Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - Canada Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
- Europe
  - Europe Insomnia Therapeutics Market, By Treatment type
    - Drugs
      - Benzodiazepines
      - Nonbenzodiazepines
      - Antidepressants
      - Orexin antagonists
      - Melatonin antagonists
      - Others
    - Devices
  - Europe Insomnia Therapeutics Market, By Sales channel
    - Prescription
    - Over-the-Counter (OTC)
  - The U.K.
    - U.K. Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - U.K. Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
  - Germany
    - Germany Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - Germany Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
- Asia Pacific
  - Asia Pacific Insomnia Therapeutics Market, By Treatment type
    - Drugs
      - Benzodiazepines
      - Nonbenzodiazepines
      - Antidepressants
      - Orexin antagonists
      - Melatonin antagonists
      - Others
    - Devices
  - Asia Pacific Insomnia Therapeutics Market, By Sales channel
    - Prescription
    - Over-the-Counter (OTC)
  - Japan
    - Japan Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - Japan Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
  - China
    - China Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - China Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)
- Latin America
- MEA
  - MEA Insomnia Therapeutics Market, By Treatment type
    - Drugs
      - Benzodiazepines
      - Nonbenzodiazepines
      - Antidepressants
      - Orexin antagonists
      - Melatonin antagonists
      - Others
    - Devices
  - MEA Insomnia Therapeutics Market, By Sales channel
    - Prescription
    - Over-the-Counter (OTC)
  - South Africa
    - South Africa. Insomnia Therapeutics Market, By Treatment type
      - Drugs
        
        Benzodiazepines
        
        Nonbenzodiazepines
        
        Antidepressants
        
        Orexin antagonists
        
        Melatonin antagonists
        
        Others
      - Devices
    - South Africa Insomnia Therapeutics Market, By Sales channel
      - Prescription
      - Over-the-Counter (OTC)

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2014 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.